AAAAAA

   
Results: 1-24 |
Results: 24

Authors: BRUERA E BELZILE M PITUSKIN E FAINSINGER R DARKE A HARSANYI Z BABUL N FORD I
Citation: E. Bruera et al., RANDOMIZED, DOUBLE-BLIND, CROSS-OVER TRIAL COMPARING SAFETY AND EFFICACY OF ORAL CONTROLLED-RELEASE OXYCODONE WITH CONTROLLED-RELEASE MORPHINE IN PATIENTS WITH CANCER PAIN, Journal of clinical oncology, 16(10), 1998, pp. 3222-3229

Authors: BABUL N PROVENCHER L LABERGE F HARSANYI Z MOULIN D
Citation: N. Babul et al., COMPARATIVE EFFICACY AND SAFETY OF CONTROLLED-RELEASE MORPHINE SUPPOSITORIES AND TABLETS IN CANCER PAIN, Journal of clinical pharmacology, 38(1), 1998, pp. 74-81

Authors: WATSON CPN BABUL N
Citation: Cpn. Watson et N. Babul, EFFICACY OF OXYCODONE IN NEUROPATHIC PAIN - A RANDOMIZED TRIAL IN POSTHERPETIC NEURALGIA, Neurology, 50(6), 1998, pp. 1837-1841

Authors: DARKE AC BABUL N FREDERICK P
Citation: Ac. Darke et al., USE OF RECTAL MEDICATIONS IN PALLIATIVE CARE, Journal of pain and symptom management, 13(6), 1997, pp. 314-315

Authors: JACOBSON SJ KOPECKY EA JOSHI P BABUL N
Citation: Sj. Jacobson et al., RANDOMIZED TRIAL OF ORAL MORPHINE FOR PAINFUL EPISODES OF SICKLE-CELLDISEASE IN CHILDREN, Lancet, 350(9088), 1997, pp. 1358-1361

Authors: HAGEN NA BABUL N
Citation: Na. Hagen et N. Babul, COMPARATIVE CLINICAL EFFICACY AND SAFETY OF A NOVEL CONTROLLED-RELEASE OXYCODONE FORMULATION AND CONTROLLED-RELEASE HYDROMORPHONE IN THE TREATMENT OF CANCER PAIN, Cancer, 79(7), 1997, pp. 1428-1437

Authors: PELOSO P BELLAMY N BENSEN W THOMPSON G BABUL N
Citation: P. Peloso et al., A DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED TRIAL OF CONTROLLED-RELEASE CODEINE IN OSTEOARTHRITIS OF HIP AND KNEE, Arthritis and rheumatism, 40(9), 1997, pp. 331-331

Authors: BRUERA E SEIFERT L WATANABE S BABUL N DARKE A HARSANYI Z SUAREZALMAZOR M
Citation: E. Bruera et al., CHRONIC NAUSEA IN ADVANCED CANCER-PATIENTS - A RETROSPECTIVE ASSESSMENT OF A METOCLOPRAMIDE-BASED ANTIEMETIC REGIMEN, Journal of pain and symptom management, 11(3), 1996, pp. 147-153

Authors: DHALIWAL HS SLOAN P ARKINSTALL WW THIRLWELL MP BABUL N HARSANYI Z DARKE AC
Citation: Hs. Dhaliwal et al., RANDOMIZED EVALUATION OF CONTROLLED-RELEASE CODEINE AND PLACEBO IN CHRONIC CANCER PAIN, Journal of pain and symptom management, 10(8), 1995, pp. 612-623

Authors: BABUL N DARKE AC HAIN R
Citation: N. Babul et al., HYDROMORPHONE AND METABOLITE PHARMACOKINETICS IN CHILDREN, Journal of pain and symptom management, 10(5), 1995, pp. 335-337

Authors: BABUL N DARKE AC HAGEN N
Citation: N. Babul et al., HYDROMORPHONE METABOLITE ACCUMULATION IN RENAL-FAILURE, Journal of pain and symptom management, 10(3), 1995, pp. 184-186

Authors: BRUERA E FAINSINGER R SPACHYNSKI K BABUL N HARSANYI Z DARKE AC
Citation: E. Bruera et al., CLINICAL EFFICACY AND SAFETY OF A NOVEL CONTROLLED-RELEASE MORPHINE SUPPOSITORY AND SUBCUTANEOUS MORPHINE IN CANCER PAIN - A RANDOMIZED EVALUATION, Journal of clinical oncology, 13(6), 1995, pp. 1520-1527

Authors: ARKINSTALL W SANDLER A GOUGHNOUR B BABUL N HARSANYI Z DARKE AC
Citation: W. Arkinstall et al., EFFICACY OF CONTROLLED-RELEASE CODEINE IN CHRONIC NONMALIGNANT PAIN -A RANDOMIZED, PLACEBO-CONTROLLED CLINICAL-TRIAL, Pain, 62(2), 1995, pp. 169-178

Authors: BRUERA E FAINSINGER R SPACHYNSKI K BABUL N HARSANYI Z DARKE AC
Citation: E. Bruera et al., STEADY-STATE PHARMACOKINETIC EVALUATION OF A NOVEL, CONTROLLED-RELEASE MORPHINE SUPPOSITORY AND SUBCUTANEOUS MORPHINE IN CANCER PAIN, Journal of clinical pharmacology, 35(7), 1995, pp. 666-672

Authors: HAGEN N THIRLWELL MP DHALIWAL HS BABUL N HARSANYI Z DARKE AC
Citation: N. Hagen et al., STEADY-STATE PHARMACOKINETICS OF HYDROMORPHONE AND HYDROMORPHONE-3-GLUCURONIDE IN CANCER-PATIENTS AFTER IMMEDIATE AND CONTROLLED-RELEASE HYDROMORPHONE, Journal of clinical pharmacology, 35(1), 1995, pp. 37-44

Authors: BABUL N DHALIWAL H SLOAN P ARKINSTALL W THIRLWELL M HARSANYI Z DARKE A
Citation: N. Babul et al., ANALGESIC EFFICACY AND SAFETY OF CONTROLLED-RELEASE CODEINE AND PLACEBO IN CANCER PAIN, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 137-137

Authors: DARKE A MOULIN D PROVENCHER L LABERGE F HARSANYI Z BABUL N
Citation: A. Darke et al., EFFICACY, SAFETY AND PHARMACOKINETICS OF CONTROLLED-RELEASE MORPHINE SUPPOSITORIES AND TABLETS IN CANCER PAIN, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 165-165

Authors: BABUL N HAGEN N THIRLWELL M DHALIWAL H HARSANYI Z DARKE A
Citation: N. Babul et al., STEADY-STATE DISPOSITION OF HYDROMORPHONE AND HYDROMORPHONE-3-GLUCURONIDE IN CANCER-PATIENTS, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 165-165

Authors: BABUL N DARKE AC
Citation: N. Babul et Ac. Darke, RELIABILITY AND ACCURACY OF MEMORY FOR ACUTE PAIN, Pain, 57(1), 1994, pp. 131-132

Authors: FRADETTE M BABICH M FRIESEN EG ARCHIBALD JS BABUL N
Citation: M. Fradette et al., SERUM THEOPHYLLINE PROFILE WITH ONCE-DAILY THEOPHYLLINE (UNIPHYL) FOLLOWING CONVERSION FROM INTRAVENOUS THEOPHYLLINE IN ADULT ASTHMATIC-PATIENTS, Clinical therapeutics, 16(2), 1994, pp. 160-168

Authors: HAYS H HAGEN N THIRLWELL M DHALIWAL H BABUL N HARSANYI Z DARKE AC
Citation: H. Hays et al., COMPARATIVE CLINICAL EFFICACY AND SAFETY OF IMMEDIATE-RELEASE AND CONTROLLED-RELEASE HYDROMORPHONE FOR CHRONIC SEVERE CANCER PAIN, Cancer, 74(6), 1994, pp. 1808-1816

Authors: BRUERA ED MACEACHERN TJ SPACHYNSKI KA LEGATT DF MACDONALD RN BABUL N HARSANYI Z DARKE AC
Citation: Ed. Bruera et al., COMPARISON OF THE EFFICACY, SAFETY, AND PHARMACOKINETICS OF CONTROLLED-RELEASE AND IMMEDIATE-RELEASE METOCLOPRAMIDE FOR THE MANAGEMENT OF CHRONIC NAUSEA IN PATIENTS WITH ADVANCED CANCER, Cancer, 74(12), 1994, pp. 3204-3211

Authors: FRASER IM BUTTOO KM WALKER SE STEWART JH BABUL N
Citation: Im. Fraser et al., EFFECTS OF CIMETIDINE AND RANITIDINE ON THE PHARMACOKINETICS OF A CHRONOTHERAPEUTICALLY FORMULATED ONCE-DAILY THEOPHYLLINE PREPARATION (UNIPHYL(R)), Clinical therapeutics, 15(2), 1993, pp. 383-393

Authors: BABUL N DARKE AC
Citation: N. Babul et Ac. Darke, DISPOSITION OF MORPHINE AND ITS GLUCURONIDE METABOLITES AFTER ORAL AND RECTAL ADMINISTRATION - EVIDENCE OF ROUTE SPECIFICITY, Clinical pharmacology and therapeutics, 54(3), 1993, pp. 286-292
Risultati: 1-24 |